← Leaderboards
Robert M Shanks
Dartmouth College
$6,095,706
Attributed
$6,095,706
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $886.8K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,095,706 · 5
By mechanism
R01$6,048,410 · 4
F32$47,296 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Bruce A. Stanton$36,066,326
- David A. Leib$22,334,432
Others in their field
Top investigators on “Virulence”
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Joseph Heitman · Duke University$29,765,716
- Vanessa Sperandio · University Of Wisconsin-Madison$29,177,087
- Adolfo Garcia-Sastre · Jackson Laboratory$28,883,338
- John J Mekalanos · Harvard Medical School$28,747,360
- Scott J Hultgren · Washington University$28,322,020
Research focus
VirulenceBlindnessCorneaIn VivoKeratitisVirulence FactorsIn VitroInfectionVisionOryctolagus CuniculusPathogenesisEye InfectionsBacteriaAntibioticsPathogenicityPreventPathogenGenesAntibiotic ResistanceUnited StatesLaboratoriesMutantResistanceCells
Grant awards (17)
Extensively drug resistant Pseudomonas aeruginosa keratitis outbreak strain:  virulence mechanisms and mitigation$420,591
R01 · FY2025 · EY · contact PI
Extensively drug resistant Pseudomonas aeruginosa keratitis outbreak strain:  virulence mechanisms and mitigation$488,639
R01 · FY2024 · EY · contact PI
Rise of lasR mutant Pseudomonas aeruginosa keratitis$398,154
R01 · FY2024 · EY · contact PI
Rise of lasR mutant Pseudomonas aeruginosa keratitis$398,154
R01 · FY2023 · EY · contact PI
Rise of lasR mutant Pseudomonas aeruginosa keratitis$386,210
R01 · FY2022 · EY · contact PI
Rise of lasR mutant Pseudomonas aeruginosa keratitis$387,554
R01 · FY2021 · EY · contact PI
NOT-NS-20-030: Use of anchored biologics to treat vesicant induced neovascularization$115,358
R01 · FY2021 · EY · contact PI
Bacterial Factors that Regulate Ocular Host-Pathogen Interactions and Microbial Keratitis$444,382
R01 · FY2020 · EY · contact PI
Bacterial Factors that Regulate Ocular Host-Pathogen Interactions and Microbial Keratitis$437,508
R01 · FY2019 · EY · contact PI
Bacterial Factors that Regulate Ocular Host-Pathogen Interactions and Microbial Keratitis$395,635
R01 · FY2018 · EY · contact PI
Bacterial Factors that Regulate Ocular Host-Pathogen Interactions and Microbial Keratitis$388,132
R01 · FY2017 · EY · contact PI
Novel virulence and exoenzyme regulators$360,393
R01 · FY2014 · AI · contact PI
Novel virulence and exoenzyme regulators$339,168
R01 · FY2013 · AI · contact PI
Novel virulence and exoenzyme regulators$361,229
R01 · FY2012 · AI · contact PI
Novel virulence and exoenzyme regulators$361,629
R01 · FY2011 · AI · contact PI
Novel virulence and exoenzyme regulators$365,674
R01 · FY2010 · AI · contact PI
Role of the SasAB locus in S. aureus Biofilms$47,296
F32 · FY2004 · GM